Sheaff Brock Investment Advisors LLC cut its position in shares of HCA Healthcare Inc (NYSE:HCA) by 8.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,335 shares of the company’s stock after selling 300 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in HCA Healthcare were worth $451,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of HCA. Dimensional Fund Advisors LP grew its holdings in shares of HCA Healthcare by 3.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 544,838 shares of the company’s stock valued at $67,797,000 after buying an additional 16,992 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of HCA Healthcare by 10.0% during the fourth quarter. Geode Capital Management LLC now owns 3,414,676 shares of the company’s stock valued at $424,189,000 after buying an additional 310,086 shares during the last quarter. Valeo Financial Advisors LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at $66,000. Mercer Global Advisors Inc. ADV purchased a new stake in shares of HCA Healthcare during the first quarter valued at $948,000. Finally, First Manhattan Co. grew its holdings in shares of HCA Healthcare by 20.2% during the first quarter. First Manhattan Co. now owns 1,310 shares of the company’s stock valued at $170,000 after buying an additional 220 shares during the last quarter. 70.23% of the stock is owned by institutional investors.
In related news, major shareholder Patricia F. Elcan purchased 250 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, August 6th. The stock was purchased at an average price of $124.10 per share, for a total transaction of $31,025.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Robert A. Waterman sold 33,786 shares of the company’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the transaction, the senior vice president now owns 279,551 shares of the company’s stock, valued at approximately $37,733,793.98. The disclosure for this sale can be found here. 2.70% of the stock is owned by corporate insiders.
Shares of HCA Healthcare stock traded down $3.08 during trading hours on Wednesday, reaching $122.72. The stock had a trading volume of 421,515 shares, compared to its average volume of 1,741,663. The company’s 50 day simple moving average is $135.68. The stock has a market cap of $42.86 billion, a price-to-earnings ratio of 12.56, a PEG ratio of 1.09 and a beta of 0.85. HCA Healthcare Inc has a twelve month low of $110.31 and a twelve month high of $147.42.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing analysts’ consensus estimates of $2.49 by ($0.28). The firm had revenue of $12.60 billion during the quarter, compared to analyst estimates of $12.61 billion. HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The company’s revenue was up 9.3% on a year-over-year basis. During the same quarter last year, the company posted $2.29 EPS. On average, equities research analysts anticipate that HCA Healthcare Inc will post 10.35 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 3rd will be given a dividend of $0.40 per share. The ex-dividend date is Friday, August 30th. This represents a $1.60 annualized dividend and a dividend yield of 1.30%. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.
HCA has been the subject of a number of research reports. Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 target price for the company. in a research report on Monday, May 27th. Jefferies Financial Group set a $158.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, April 17th. Stephens set a $150.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, August 7th. Raymond James upgraded shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $115.00 to $135.00 in a research report on Tuesday, April 23rd. Finally, Goldman Sachs Group upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating and boosted their target price for the company from $147.00 to $160.00 in a research report on Wednesday, July 10th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and seventeen have given a buy rating to the company’s stock. HCA Healthcare presently has a consensus rating of “Buy” and an average price target of $153.35.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Story: Percentage Decliners
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.